Fourpath Capital Management’s Eli Lilly LLY Stock Holding History

Fourpath Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.5M	Sell	13,387 -181	-1%	-$214K	2.01%	10
2026 Q2	$16.3M	Sell	13,568 -55	-0.4%	-$56.2K	2.14%	9
2026 Q1	$12.5M	Sell	13,623 -1,590	-10%	-$1.61M	1.8%	11
2025 Q4	$16.3M	Sell	15,213 -21	-0.1%	-$20.1K	2.24%	9
2025 Q3	$11.6M	Sell	15,234 -184	-1%	-$137K	1.65%	19
2025 Q2	$12M	Sell	15,418 -288	-2%	-$224K	1.89%	11
2025 Q1	$13M	Sell	15,706 -199	-1%	-$166K	2.26%	8
2024 Q4	$12.3M	Sell	15,905 -2,479	-13%	-$2.05M	2.27%	9
2024 Q3	$16.3M	Buy	18,384 +18,049	+5,388%	+$16.2M	3%	4
2024 Q2	$303K	Buy	335 +1	+0.3%	+$800	0.22%	91
2024 Q1	$260K	Buy	+334	New	+$238K	0.18%	108

Other funds holding LLY

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Fourpath Capital Management's LLY Position: Q3 2026 in Review

Fourpath Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2026, selling an estimated $214K and leaving 13,387 shares worth $15.5M. The position accounts for 2.01% of the portfolio, ranked #10.

Fourpath Capital Management first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $16.3M in Q4 2025. 850 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Fourpath Capital Management held 13,387 shares of Eli Lilly worth $15.5M as of Q3 2026.
Fourpath Capital Management sold 181 Eli Lilly shares in Q3 2026, an estimated $214K.
Eli Lilly made up 2.01% of Fourpath Capital Management's portfolio in Q3 2026, its #10 holding.
Fourpath Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
Fourpath Capital Management's Eli Lilly position peaked at $16.3M in Q4 2025.
850 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.